Dual Integrin αvβ3 and GRPR Targeting PET Imaging Agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual Integrin αvβ3 and GRPR Targeting PET Imaging Agent, covering 2016-04-22 to 2016-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients [Phase 1]